HfPT – Health from Portugal

Project Name

HfPT – Health from Portugal

Project code

C630926586-00465198

Investment name

RE-C05-i01.01 – Mobilizing Agendas/Alliances for Business Innovation

Consortium Leader

Prológica, Sistemas Informáticos S.A.

Agenda Description

The HfPT agenda aims to position Portugal as an international reference hub in the design, development, and production of advanced solutions aimed at health markets, based on innovation and technology. HfPT will focus on 4 areas:

1. development of smart health solutions aimed at the digital medtech segment;
2. creation of a national smart health data repository of international reference;
3. enabling the growth and sophistication of the clinical studies segment in the country; and
4. creating solutions that enhance the potential of the ecosystem for collecting and benchmarking clinical data and associated costs with healthcare provision.

These commitments will be addressed by a consortium of 88 co-developers, who complement each other technically and technologically, concentrating the necessary capacity to achieve the ambitious goals set, which aim to launch 99 new products.

Start date

01-11-2021

End date

31-12-2025

Total investment

90M€

RRF (Recovery and Resilience Facility) Incentive / Next Generation EU

70M€

Beneficiary

Altice Labs, S. A.

Investment (Beneficiary)

443.419,56 €

Incentive (Beneficiary)

177.367,82 €

Goals, activities, and expected results

Altice Labs is involved in the following Health and Safety Plan where the expected results are described below:

WP4

• A4.1.1 – (Glintt Healthcare Solutions, FCUL, INESCTEC, CINTESIS) – Clinical Data Repository Viewer

Goal: The goal is to create a Clinical Data Repository with health standards structure namely with FHIR objects and with standard terminologies (SNOMED, LOINC, etc.).

Role of Altice Labs:

1. Participation in the system architecture design and the specification of standardized external communication interfaces;
2. Focus on telemonitoring data; adapt SmartAL to build a new EHR.

• A4.4.1 – (Healthy Systems, Glintt, INESCTEC, FhP-AICOS, P5, Altice Labs) – Cybersecurity guidelines for healthcare systems

Goal: to develop and disseminate a set of cybersecurity guidelines for the healthcare area aimed at guiding healthcare providers’ IT teams in protecting systems, services, and applications – with special attention to new eHealth services and the GDPR.

Role of Altice Labs:

A1. Participation in drawing up the questionnaire to assess the current situation and survey the needs related to cybersecurity in the healthcare sector.

A7. Preparation of cybersecurity guidelines related to network and cloud services.

• A4.4.2 – (Healthy Systems, VirtualCare, Glintt, INESCTEC, P5, CINTESIS, Altice Labs) – User consent manager

Goal: to develop a consent management system that can be parameterized to the healthcare context to be applied; the system should implement a broad set of consent directives that allow the user to express their will, including instructions to allow, withhold, withdraw, change or revoke consent to collect, use or disclose personal health information.

Role of Altice Labs:

A1. Participation in the survey to identify requirements and needs related to consent management, user engagement, and auditability.

A3. Collaboration in designing models and algorithms to be applied in consent management.

WP5

• A5.2.1 (Altice Labs, F3M, FhP-AICOS, Glintt HS, Gripwise, UA, VirtualCare, Wiselife, Wisify) – Consultation and geriatric assessment of the elderly with sensors and surveys

Goal: to build a platform for assessment and early intervention in a set of established parameters to maximize the longevity of the autonomy of the elderly, promoting active aging and a higher quality of life; to carry out a geriatric assessment of the elderly using devices for clinical measurement of sarcopenia (e.g. strength, muscle mass, and march quality) and cognitive assessment questionnaires.

Role of ALB:

1. participation in the design of the overall architecture of the solution that integrates SmartAL
2. integration of devices, applications, and questionnaires into SmartAL
3. integration with external ERP systems using FIRE/HL7.

• A5.2.2 – (Altice Labs, CCG, P5) – Referral associated with Intelligent Symptom Screening and Digital Consultation

Goal: to build an intelligent system that supports the screening of patients according to their symptoms and allows referral to specialized health care by health professionals; to include teleconsultation and remote monitoring of patients.

Role of Altice Labs:

1. preparation of specialized questionnaires to be made available to both the user and the health professional
2. integration with external ERP entities using FIRE/HL7
3. integration of decision support systems in the area of Chronic obstructive pulmonary disease (COPD).

• A5.2.3 (Altice Labs, F3M, GripWise, 2CA-Braga, VirtualCare, Wisify) – Assessment of Frailty and Sarcopenia in the elderly

Goal: To integrate and evaluate on the market a medical device comprising a dynamometer, an adipometer, and a set of questionnaires to assess the nutritional and physical status and degree of mobility of the elderly, acting as an auxiliary tool in the diagnosis of clinical signs of frailty and sarcopenia.

Role of Altice Labs:

1. integration of data from sarcopenia assessment devices (i.e. dynamometer and adipometer)
2. implementation of additional sarcopenia control functionalities in the SmartAL mobile application.

• A5.2.5 (Altice Labs, Plux, Glintt HS, Everythink, INESCTEC) – Remote teleconsultation tools with telemonitoring instruments

Goal: The aim is to develop a set of products that promote improvements in care provision, focusing on 3 fundamental areas: (i) health promotion, (ii) digital consultation support tools, and (iii) evaluation and monitoring tools; in addition, the aim is to integrate and evaluate sensors (otoscope, stethoscope, dermatoscope, echograph) for diagnosing congenital and acquired heart diseases, especially in regions far from large urban centers.

Role of Altice Labs:

1. Participate in the integration of sensors and the tests inherent to their use.

Beneficiaries:

Co-financed by: